Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Pfizer CEO awarded Genesis Prize for developing coronavirus vaccine, will donate winnings to Holocaust education

(JTA) — Albert Bourla, the chief executive officer of Pfizer, was named the winner of the 2022 Genesis Prize, the award sometimes called the “Jewish Nobel.”

The award, which “honors extraordinary individuals for their outstanding professional achievement, contribution to humanity, and commitment to Jewish values,” was announced early Wednesday morning. The award will be presented by Israeli President Isaac Herzog at a ceremony in Jerusalem June 29.

The announcement of the prize noted Bourla’s work at Pfizer, which developed one of the first vaccines to protect against the coronavirus. Bourla’s win was determined by an online vote in which 200,000 people participated, according to the announcement.

“I accept it humbly and on behalf of all my Pfizer colleagues who answered the urgent call of history these past two years and together bent the arc of our common destiny,” Bourla said in a statement. “I was brought up in a Jewish family who believed that each of us is only as strong as the bonds of our community; and that we are all called upon by God to repair the world. I look forward to being in Jerusalem to accept this honor in person, which symbolizes the triumph of science and a great hope for our future.”

The Genesis Prize comes with a $1 million prize. Past recipients, including Steven Spielberg, Michael Douglas, Michael Bloomberg, Natalie Portman and Natan Sharansky, have donated the winnings to philanthropic causes.

Bourla is set to donate his prize money to “projects aimed at preserving the memory of the victims of the Holocaust, with a particular emphasis on the tragedy suffered by the Greek Jewish community.” Bourla’s parents, both from Greece, were both Holocaust survivors.

Launched in 2013 by a group of Russian-Jewish philanthropists that includes current foundation chairman Stan Polovets, the prize is financed through a permanent endowment of $100 million established by The Genesis Prize Foundation.


The post Pfizer CEO Albert Bourla awarded Genesis Prize for work developing coronavirus vaccine appeared first on Jewish Telegraphic Agency.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.